Gillian Huang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Allogeneic Blood and Marrow Transplant (BMT) survivors are at high risk of secondary cancers. Although current guidelines endorse survivors following Country-specific general population screening recommendations to mitigate this risk, little is known about cancer screening adherence in Australian BMT survivors. We conducted a cross-sectional survey of 441(More)
  • 1